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Abstract  
Polyketide synthase (PKS) engineering is an attractive method to generate new molecules such 
as commodity, fine and specialty chemicals. A central challenge in PKS design is replacing a 
partially reductive module with a fully reductive module through a reductive loop exchange, 
thereby generating a saturated -carbon. In this work, we sought to establish an engineering 
strategy for reductive loop exchanges based on chemoinformatics, a field traditionally used in 
drug discovery. We first introduced a set of donor reductive loops of diverse genetic origin and 
chemical substrate structures into the first extension module of the lipomycin PKS (LipPKS1). 
These results demonstrated that chemical similarity between the substrate of the donor loops 
and recipient LipPKS1 correlated with product titers. Consequently, we identified donor loops 
with substrates chemically similar to LipPKS1 for further reductive loop exchanges, and we 
observed a statistically significant correlation with production. Reductive loops with the highest 
chemical similarity resulted in production of branched, short-chain fatty acids reaching a titer of 
165 mg/L in Streptomyces albus J1074.  Collectively, our work formulizes a new 
chemoinformatic paradigm for de novo PKS biosynthesis which may accelerate the production 
of valuable bioproducts.  
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Intro 
As the architecture of Type I PKSs determines molecular structure, rational 
reprogramming of PKS enzymes for the biosynthesis of new polyketides has been a major 
research thrust over the past three decades.1–3 Like fatty acid synthases, PKSs extend the 
growing chain from the ketosynthase (KS) domain with a malonyl-CoA analog loaded onto the 
acyl carrier protein (ACP) by the acyltransferase (AT) domain through a decarboxylative Claisen 
condensation reaction. Unlike fatty acid synthases, which faithfully produce saturated fatty 
acids, PKSs have variability in -carbonyl reduction, an attractive feature for molecular design. 
After chain extension, the -carbonyl reduction state is determined by the reductive domains 
within the module, namely the ketoreductase (KR), dehydratase (DH), and enoylreductase (ER), 
which generate the -hydroxyl, α-  alkene, or saturated -carbons respectively, when 
progressively combined. As the degree of -carbon reduction is an important feature in 
molecular design, multiple studies have reported the engineering of a PKS module for various 
oxidation states of the -carbon.4–8 However, design principles for introduction of reductive loop 
exchanges (i.e. KR-DH-ER domains) into partially reductive modules have not yet been 
developed. In this work, we compare bioinformatic and chemoinformatic approaches to guide 
reductive loop exchanges and formalize a new paradigm based on the chemical similarity of the 
substrate. 
Chemoinformatics, an interdisciplinary field  blending computational chemistry, 
molecular modeling and statistics, was initially developed for drug discovery through analysis of 
structure-activity relationships.9 Recently, we suggested that a  chemoinformatic approach to 
PKS engineering could be valuable, particularly in reductive loop exchanges due to the 
dependence of the KR and DH domains on substrate size 1. For example, due to a hydrophobic 
catalytic tunnel,10,11 acyl chain length had a critical influence on dehydration in both stand-alone 
DH12 and full PKS module studies.7 Moreover, a previous study of engineered reductive loop 
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swaps resulted in a correlation between production and substrate size similarity of the donor 
reductive loops and the recipient module.13 Chemoinformatic methods such as atom pair (AP) 
similarity and maximum common substructure (MCS) similarity could be used to describe the 
substrate profiles for catalysis by these domains. AP similarity characterizes atom pairs (e.g. 
length of bond path, number of π electrons), and MCS similarity is based on identifying the 
largest common substructure between two molecules. Both similarity methods can be translated 
to a Tanimoto coefficient with a range of 0 (least similar) to 1 (most similar).14 Based on the 
substrate-dependence of the reductive domains, we hypothesized that chemosimilarity between 
the substrates of donor and acceptor modules in reductive loop exchanges would correlate with 
production levels.  
Bioinformatic studies of PKS evolution have guided engineering efforts in closely related 
biosynthetic gene clusters (BGCs).15,16 We therefore undertook a phylogenetic analysis of the 
reductive domain common to all reductive loops, the ketoreductase (KR). The KR not only 
reduces the -keto group to a -hydroxyl, but also sets the stereochemistry of the -group and, 
if a branched extender is used, sets the -carbon stereochemistry resulting in subtypes A1, A2, 
B1, B2 (Figure 1A). We generated a phylogenetic tree of every manually curated ketoreductase 
and ketosynthase in ClusterCAD, a database for Type I PKSs, totaling 72 biosynthetic gene 
clusters (BGCs) and 1077 modules (Figure 1B).17 This evolutionary reconstruction revealed 
that KR-only B1 subtypes split from a common ancestor of fatty acid synthases and iterative 
PKSs.18 As in previous investigations, we found that KR-only B1 subtypes later resulted in the 
addition of DH and DH/ER domains,19 likely through recombination.20 We extend this finding to 
note that the KR-only B1 subtype branch diverged to produce the other KR-only subtypes (i.e. 
A1, A2 and B2) (Figure 1B, Supplementary Figure 1). While KR domains cluster by the 
presence of a DH or DH-ER domains, KS domains do not phylogenetically cluster by the type of 
reductive domains active in the module (Supplementary Figure 2).19 The KRs generally 
grouped by their product types, and this suggests a link between their evolution and product 
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specificity, analogous to the evolution of KS domains of cis-AT19 and trans-AT PKS modules21,22 
towards substrate specificity. As KRs from KR-DH-ER modules evolved distinctly from KR-only 
modules, we hypothesized that the KR phylogenetic distance between the donor loops and 
acceptor module in reductive loop exchanges was unlikely to correlate with production levels.   
Results and Discussion 
To compare the importance of chemical similarity and phylogenetic distance in reductive 
loop exchanges, we swapped diverse reductive loops into the first module of the lipomycin PKS 
as the acceptor module. In our previous work, we introduced a heterologous thioesterase from 
6-deoxyerythronolide (DEBS) into the C-terminus of the first module of the lipomycin PKS 
(denoted Lip1TE); the resulting truncated PKS produced a -hydroxy acid.23 In this work, our 
experimental design was based on introducing full reductive loops using conserved residues as 
exchange sites (denoted “A”, “B” and “C”) in Lip1TE (Scheme 1).7 We selected these conserved 
residues based on our work in reductive loop exchanges in the first module of borreledin.7 To 
evaluate the effects of genetic and chemical similarity, we identified five donor reductive loops 
(IdmO, indanomycin, S. antibioticus; SpnB, spinosyn, S. spinosa; AurB, aureothin, S. 
aureofaciens; NanA2, nanchangamycin, S. nanchangensis; MAS, mycoserosic acid, M. 
marinum) to swap into Lip1TE. A pairwise comparison of phylogenetic distance as well as direct 
sequence identity illustrates that the KR domain of the three donor reductive loops IdmO, SpnB, 
and AurB are the most similar to the KR in LipPKS1 (Figure 2A). A similar trend also holds in 
the analysis of the KS domain (Supplementary Figure 3). In contrast, the NanA2 substrate is 
the most chemically similar to LipPKS1, followed by SpnB, based on AP similarity (Figure 2B) 
and MCS similarity (data not shown). With the introduction of a reductive loop swap, the 
chimeric enzymes would programmatically produce 2,4-dimethyl pentanoic acid. As in vitro PKS 
studies have shown divergence from in vivo results24,25 due to underestimation of factors 
including limiting substrate, crowding, and solubility,26 we cloned ten chimeric modules into an 
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E. coli -Streptomyces albus shuttle vector and conjugated it into Streptomyces albus J1074 
(Table S1).27  Following ten-day production runs in a rich medium, cultures of Streptomyces 
albus harboring each of the constructs were harvested and the supernatants were analyzed with 
LC-MS for product levels. 
Consistent with our hypothesis, we found a strong correlation between production titers 
of the desired product and the AP and MCS chemosimilarities of the donor and LipPKS1 
module substrates (AP Spearman Rank Correlation of Rs of 0.99 and p < 0.01; MCS Rs of 0.90 
and p = 0.04) (Figure 2C). On the other hand, no correlation between product titer and 
phylogenetic distance or sequence similarity of the KS or KR domains was found. Based on our 
bioinformatic analysis, this was not surprising as the lipomycin KR is an A2-type, evolving 
separately from a KR with a full reductive loop. This trend held with either junction A or B, 
although generally junction B chimeras resulted in higher levels of production, as demonstrated 
in a previous study of reductive loop exchanges.7 We found that substituting the donor loop 
most chemically similar to LipPKS1, NanA2, resulted in the highest titers of the desired product, 
2,4-dimethyl pentanoic acid, reaching 165 mg/L. Low titers of the intermediate 2,5-dimethyl-3-
hydroxypentanoic acid were produced, which we hypothesize is due to a comparatively lower 
rate of turnover at the energetically intensive DH domain,28 resulting in premature cleavage of 
the stalled product by hydration or by the thioesterase. As in our previous study of in vitro 
production of adipic acid, we did not detect alkene or keto acid stalled products 7. This is not 
surprising as non-functional KRs produce short chain -keto acids that spontaneously 
decarboxylate to form ketones, whereas ERs have been generally shown to rapidly reduce trans 
double bonds.  
 Based on these results, we took a chemoinformatic approach to further test our 
hypothesis that chemosimilarity is a critical factor in PKS engineering. We searched the 
ClusterCAD17 database for PKS modules with full reductive loops and substrates of high 
chemical similiarity to that of the KR of LipPKS1. The closest matches identified were PKS 
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modules from laidlomycin and monensin, which used the same substrate as nanchangamycin. 
(Figure 3A). As junction B resulted in levels of production superior to junction A, we cloned the 
reductive loops of LaidSII and MonA2 into junction B of lipomycin. The chimeric PKSs 
containing reductive loops with substrates of similar chemical structure (NanA2, LaidSII, and 
MonA2) produced higher titers of the desired fully reduced product than less chemically similar 
reductive loops. We determined a Spearman rank correlation between AP Tanimoto 
chemosimilarity and production to have an Rs of 0.89 and a p-value of less than 0.01 compared 
to a correlation of Rs of 0.85 and p value of 0.01 for MCS chemosimilarity. With divergent 
methods of chemical similarity calculations (AP and MCS), we found a statistically significant 
correlation between substrate similarity and product titer. 
In this work, we have undertaken a bioinformatic and chemoinformatic analysis of 
reductive loop exchanges. Through a phylogenetic reconstruction, we suggested that the 
evolutionary history of KR-only modules does not reveal useful information for predicting 
production rates in reductive loop swaps; in fact, phylogenetic distance and sequence similarity 
between donor KRs of full reductive loops and recipient KRs of partial loops did not correlate to 
production. Highlighting previous literature regarding the importance of substrate size in 
reductive domains, we hypothesized that the field of chemoinformatics, traditionally used to 
study structure-activity relationships in drug discovery, could be applied to PKS engineering to 
better predict production results. Using different reductive loops of varying phylogenetic and 
chemical similarity, we determined that chemosimilarity had a strong correlation with product 
titers. Based on these findings, we selected two more reductive loops with the most chemically 
similar substrates to LipPKS1 and found higher levels of production. The analysis of our results 
and previous experiments formalize a new paradigm in PKS engineering based on the 
chemosimilarity of the substrate between the donor and recipient modules. These design 
principles may fast-track the combinatorial approach currently taken for de novo biosynthesis 
and develop a framework to more rapidly produce valuable biochemicals.  
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Scheme 1. Experimental design of PKS reductive loop swaps. Conserved residues are 
identified through multiple sequence alignment surrounding the reductive domains (“A”, “B” and 
“C”). Donor reductive loops are inserted into the native lipomycin module, and the DEBS 
thioesterase cleaves the product. 
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Figure 1. Bioinformatic analysis of reductive loop exchanges. A) KR subtypes determine the 
stereochemistry of the -hydroxyl and -carbon B) Phylogenetic tree of the ketoreductase (KR) 
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Figure 2. Phylogenetic and chemical similarity effects on reductive loop exchanges. A) 
Phylogenetic similarity of the native Lip1 KR-only A2 subtype domain to each donor KR B1 
subtype containing a DH and ER, normalized to the most similar and least similar KR domain in 
ClusterCad. The value above each bar denotes the sequence identity comparison. B) AP 
chemical similarity between the native Lip1 KR domain and each of the donor KR domains in 
this study. Chemical structures display native KR substrate in each module C) Polyketide 
production of engineered PKSs at both junction “A” and junction “B”.  
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Figure 3. A chemoinformatic approach to reductive loop exchanges. A) A search in 
ClusterCad revealed the closest substrates to the first module of lipomycin containing a full 
reductive loop B) Production levels of reductive loop exchanges with the closest KR substrate 
similarity to LipPKS1 (MonAII, LaidSII and NanA2) compared to donor loops with less KR 
substrate similarity (MAS, IdmO, AurB, SpnB). 
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